Drive launches PulmO2 for disadvantaged regions
By HME News Staff
Updated 12:47 PM CDT, Mon October 14, 2024
PORT WASHINGTON, N.Y. – Drive DeVilbiss Healthcare has launched the PulmO2 Oxygen Concentrator to improve access to oxygen therapy in low- and middle-income countries. With more than a million preventable deaths annually from hypoxemia in these regions, the PulmO2 addresses a critical gap in healthcare. The PulmO2's advanced features make it highly effective in resource-limited settings, including energy efficiency, solar compatibility, wide voltage range, durability, high altitude operation and user-friendliness. To ensure effective delivery and operation, DDH collaborated with Sanrai International, a key partner experienced in bringing medical equipment to underserved areas, to tap into the intricacies of underserved regions and ensure the concentrator's effectiveness in the most challenging settings. "Our mission has always been to lead in creating innovative healthcare solutions that improve lives," said Derek Lampert, DDH CEO . "The PulmO2 is a testament to our commitment to transforming challenging healthcare environments. We are proud to partner with Sanrai to ensure that no patient, regardless of location, is left without access to critically important oxygen."
Comments